Deferasirox and Neupogen drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Deferasirox (deferasirox) and Neupogen (filgrastim). Common drug interactions include acute myeloid leukaemia among females and basal cell carcinoma among males.

The phase IV clinical study analyzes what interactions people have when they take Deferasirox and Neupogen. It is created by eHealthMe based on reports of 26 people who take the same drugs from the FDA, and is updated regularly.

What is Deferasirox?

Deferasirox has active ingredients of deferasirox. eHealthMe is studying from 2,641 Deferasirox users. Check the latest studies of Deferasirox.

What is Neupogen?

Neupogen has active ingredients of filgrastim. It is often used in agranulocytosis. eHealthMe is studying from 23,898 Neupogen users. Check the latest studies of Neupogen.

On Jul, 14, 2026

26 people who take Deferasirox and Neupogen together, and have interactions are studied.

Deferasirox and Neupogen drug interactions.

What are the common drug interactions of Deferasirox and Neupogen, by gender? *:

female:

Acute myeloid leukaemia (acute cancer in which the bone marrow makes abnormal myeloblasts)
White blood cell count decreased
Anaemia (lack of blood)
Bk virus infection
Cytomegalovirus infection
Haemochromatosis (body to absorb more iron than usual from food)
Duodenal ulcer haemorrhage (bleeding duodenal ulcer)
Sepsis (a severe blood infection that can lead to organ failure and death)
Subdural haematoma (blood collects between the skull and the surface of the brain)
Cardiac failure congestive

male:

Basal cell carcinoma (a skin cancer, it rarely metastasizes or kills)
Blood lactate dehydrogenase increased
Drug ineffective
Dyspnoea (difficult or laboured respiration)
Haematuria (presence of blood in urine)
Haemolysis (breaking open of red blood cells and the release of haemoglobin into the surrounding fluid)
Hypertension (high blood pressure)
Local swelling (swelling at the site of some application of substance or injury)
Oxygen saturation decreased
Haemoglobin decreased

What are the common drug interactions of Deferasirox and Neupogen, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

Adenovirus infection
Bk virus infection
Blastocystis infection
Cytomegalovirus infection
Haemochromatosis (body to absorb more iron than usual from food)
Sepsis (a severe blood infection that can lead to organ failure and death)

10-19:

Bk virus infection
Cystitis haemorrhagic (blood in the urine and painful voiding)
Cytomegalovirus infection
Haemochromatosis (body to absorb more iron than usual from food)

20-29:

n/a

30-39:

n/a

40-49:

Contusion (a type of hematoma of tissue in which capillaries)
Death

50-59:

Acute myeloid leukaemia (acute cancer in which the bone marrow makes abnormal myeloblasts)
Cardiac failure congestive
Fungal infection
Graft versus host disease (the donated bone marrow or stem cells view the recipient's body as foreign, and the donated cells/bone marrow attack the body)
Staphylococcal infection (an infection with staphylococcus bacteria)
Cerebral infarction (less blood supply to brain resulting tissue damage)
Cerebrovascular disorder (disease of brain)

60+:

Haemoglobin decreased
Neutrophil count decreased (less than normal number of neutrophil a type of blood cell)
Duodenal ulcer haemorrhage (bleeding duodenal ulcer)
Subdural haematoma (blood collects between the skull and the surface of the brain)
Lung infection
Pleural effusion (water on the lungs)
Serum sickness-like reaction
Abdominal pain upper
Antipsychotic drug level increased
Anxiety

What are the existing conditions these people have? *

Myelodysplastic Syndrome (a group of conditions that occur when the blood-forming cells in the bone marrow are damaged): 6 people, 23.08%
Paroxysmal Nocturnal Haemoglobinuria (haemoglobin in the urine): 5 people, 19.23%
Haemosiderosis (general increase in tissue iron stores without associated tissue damage): 4 people, 15.38%
Bone Marrow Conditioning Regimen: 4 people, 15.38%
Aplastic Anemia: 3 people, 11.54%
Tremor (trembling or shaking movements in one or more parts of your body): 2 people, 7.69%
Reflux Oesophagitis (an oesophageal mucosal injury that occurs of gastric contents into the oesophagus): 2 people, 7.69%
Post Herpetic Neuralgia (neuralgia caused by the varicella zoster virus): 2 people, 7.69%
Oedema (fluid collection in tissue): 2 people, 7.69%
Nephrogenic Anaemia (anaemia due to kidney disease): 2 people, 7.69%

* Approximation only. Some reports may have incomplete information.

Do you take Deferasirox and Neupogen?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously